The Hartford Expands Training for Medical Providers on Substance Abuse, Pain Management and Stigma

The Hartford Expands Training for Medical Providers on Substance Abuse, Pain Management and Stigma

  • 09/13/22
  • WorkersCompensation.com


Hartford, CT (WorkersCompensation.com) – Hartford, a leading workers’ compensation and disability insurer, is expanding its partnership with the Yale Program in Addiction Medicine (Yale-PAM) to provide newly developed training about substance abuse, pain management and the stigma of more medical providers treating injured workers.

“Science and empathy are both essential to addressing the current opioid crisis, and the unique training developed through our partnership has both,” said Hartford Chairman and CEO Christopher Swift. “By partnering with an internationally recognized leader in evidence-based treatments, we are advancing stigma-free education and compassionate care to help more American workers return to active, productive lives after injury.”

David Fiellin, MD, and Jeanette Tetrault, MD, FACP, FASAM, led the Yale-PAM team that developed the original program, which helps clinicians better understand opioids and work-related injuries, identify and treating acute pain and chronic pain, and assessing substance and opioid use disorders in injured workers. Hartford’s Chief Medical Officer, Adam Seidner, MD, served as a consultant to the Yale-PAM team to ensure the program focuses on improving workers’ ability to do their jobs, preventing development of chronic pain through the appropriate management of acute pain and the possibility of a safe return to work after an accident at work.

Leveraging the new curriculum, the Yale-PAM team hosted an in-depth virtual training session for 25 clinicians in June. Participants were very satisfied with the training, saying it was “comprehensive” and “interactive”. Additionally, knowledge gain between pre- and post-knowledge assessment scores was noted among participants, who averaged 88% on post-training.

Over the coming year, the Yale-PAM team will refine and update the program based on feedback from pilot participants, conduct additional virtual and in-person training sessions, and develop train-the-trainer resources so that more instructors can deliver the training.

“We are grateful for The Hartford’s unrestricted donation to support the development of a unique new educational resource that will help address the deadly opioid crisis,” said Dr. Fiellin. “With continued support, we will reach more clinicians with the new program and help countless American workers who have suffered injuries with evidence-based treatment approaches in an effort to return to work.”

The Hartford initiated the partnership with the Yale School of Medicine following a record level of overdose deaths in the United States in 2021. To address the opioid crisis, the company also supported federal funding for programs of opioid education and treatment and has advocated for federal and state reforms, such as adopting strong drug formularies, mandatory training for physicians and providers, restrictions on unnecessary opioid prescriptions, and the improved drug monitoring programs.

About Hartford

The Hartford is a leader in property and casualty insurance, group benefits and mutual funds. With over 200 years of expertise, The Hartford is widely recognized for excellence in service, sustainability practices, trust and integrity. More information about the company and its financial performance is available at https://www.thehartford.com.

The Hartford Financial Services Group, Inc., (NYSE: HIG) operates through its subsidiaries under the The Hartford brand and is headquartered in Hartford, Connecticut. For more details, please read The Hartford’s legal disclaimer.

HIG-C

Some of the statements in this release may be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. We caution investors that these forward-looking statements are not guarantees of future performance and that actual results may differ materially. . Investors should consider significant risks and uncertainties that could cause actual results to differ. These important risks and uncertainties include those discussed in our 2021 Annual Report on Form 10-K, subsequent Quarterly Reports on Forms 10-Q, and other filings we make with the Securities and Exchange Commission. We assume no obligation to update this release, which speaks as of the date of publication.

From time to time, The Hartford may use its website and/or social media, such as Twitter and Facebook, to disseminate important company information. Financial and other material information about The Hartford is regularly accessible and published on our website at https://ir.thehartford.com. Additionally, you may automatically receive email alerts and other information about The Hartford when you register your email address by visiting the “Email Alerts” section at https://ir.thehartford.com .

Source: The Hartford



comments

Be the first person to comment!


You must login or register to read and comment!

ID

You do not have an account ? Click on here to register.

About Yvonne Lozier

Check Also

NeuralMetrics launches MarketEdge – an intelligent AI-powered commercial insurance lead management platform

MarketEdge Technology Enables Insurers to Quickly Find Suitable Policyholders and develop business books NEW YORK, …